
Financial Data and Key Metrics Changes - Revenues for the year ended December 31, 2024, were $268 million, up from $187 million in 2023, with all three segments reporting increases [7] - Cost of goods sold increased from $184.7 million in 2023 to $268.2 million in 2024, aligning with revenue changes [8] - Net loss was $87.5 million for 2024, compared to a net loss of $46.4 million in 2023 [10] Business Line Data and Key Metrics Changes - California ethanol revenue increased by $57.7 million, India biodiesel revenue increased by $15.7 million, and California renewable natural gas revenue increased by $7.6 million [8] - The dairy renewable natural gas segment accounted for $5.4 million of gross profit, primarily from the sale of environmental attributes [9] Market Data and Key Metrics Changes - The price of California LCFS credits increased from $44 to $75 by February 2025, but a recent delay in implementation caused a 30% decrease in prices [15][16] - The expected increase in LCFS credit prices could reach $200 per ton, significantly benefiting Aemetis' biogas and ethanol businesses [17] Company Strategy and Development Direction - Aemetis aims to benefit from supportive public policies for domestic energy producers, focusing on biogas, ethanol, and biodiesel growth [12] - The company is preparing for an IPO of its India biodiesel business, expected in late 2025 or early 2026, contingent on new OMC orders [29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the REAP program and expects approvals for new funding soon [45][46] - The company anticipates that the approval of E15 blends will significantly expand the U.S. ethanol market by up to 50% [22][24] Other Important Information - Capital expenditures for carbon intensity reduction projects were $20.3 million in 2024, with ongoing projects aimed at increasing production capacity [10] - Aemetis has received conditional commitments for $75 million in USDA guaranteed loans for biogas digester construction [31] Q&A Session Summary Question: Confidence levels around refinancing given government spending reductions - Management has high confidence in the REAP program and expects approvals soon [45][46] Question: Insight into the OAL's request for revisions and expected delays - The complexity of the LCFS legislation led to the OAL's request for clarifications, causing a potential 120-day delay [57][58] Question: Status of India biodiesel production and OMC tender process - A new tender is expected to be issued soon, with significant inventory available for initial shipments [64][65] Question: Expected spending plans for 2025 amid regulatory turbulence - Aemetis plans a $75 million capital budget supported by USDA loans and grants, with an acceleration in biogas investments [78][79] Question: Impact of E15 approvals on ethanol margins - E15 adoption is expected to be gradual, with significant margin improvements anticipated by 2027 [84][90] Question: Timing of CARB policy implementation - Management estimates a 2-3 month timeline for CARB policy implementation, with no definitive endpoint [92] Question: Drivers of negative EBITDA results in Q4 - Oversupply and high corn prices were significant factors, but operational adjustments are expected to improve Q1 performance [98][100] Question: Expectations on D3 RVO going forward - The EPA's recent actions suggest a lower D3 RIN mandate for 2024, impacting future investment growth [106][112]